financetom
Business
financetom
/
Business
/
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
Aug 6, 2024 11:03 AM

01:38 PM EDT, 08/06/2024 (MT Newswires) -- CSX (CSX) expects a stable second half of the year even though market conditions remain mixed, UBS said in a note emailed Tuesday.

The rail freight company reported Q2 EPS of $0.49, beating estimates of $0.48, with a 2.1% volume increase and a 3.6% rise in merchandise yields. Operating expenses of $2.25 billion were $22 million below expectations, despite a $16 million accounting adjustment for engineering work, UBS said. "The impact of the adjustment was not reflected in our model and this reflects CSX's strong cost side execution in [Q2]."

Looking ahead, CSX expects continued support from chemicals, forest products and minerals volume in H2, but faces uncertainty due to a potential labor strike at East Coast ports. Metals and fertilizer volume will likely remain weak in H2, while auto volumes have already softened.

UBS lowered EPS forecast to $0.48 from $0.49 for Q3 and to $0.50 from $0.51 for Q4, citing weaker revenue per car. It reiterated buy rating on CSX and adjusted price target to $42 from $44.

Price: 34.28, Change: +1.28, Percent Change: +3.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EU drafting plans to prevent circumvention of carbon border tariff
EU drafting plans to prevent circumvention of carbon border tariff
Sep 3, 2025
BRUSSELS (Reuters) -The European Commission will propose measures this year to prevent countries from dodging its carbon border tariff, a Commission spokesperson said, as some in Brussels fear Chinese firms could reshuffle their trade to avoid the levy. Starting in January, the Carbon Border Adjustment Mechanism - the world's first carbon border tariff - will impose fees on the CO2...
Liquidia Insider Sold Shares Worth $18,957,475, According to a Recent SEC Filing
Liquidia Insider Sold Shares Worth $18,957,475, According to a Recent SEC Filing
Sep 3, 2025
03:48 AM EDT, 09/03/2025 (MT Newswires) -- Paul B Manning, Director, on August 28, 2025, sold 670,837 shares in Liquidia ( LQDA ) for $18,957,475. Following the Form 4 filing with the SEC, Manning has control over a total of 5,950,110 common shares of the company, with 3,170,549 shares held directly and 2,779,561 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819576/000141588925023468/xslF345X05/form4-09022025_110909.xml ...
Tutor Perini Insider Sold Shares Worth $4,835,567, According to a Recent SEC Filing
Tutor Perini Insider Sold Shares Worth $4,835,567, According to a Recent SEC Filing
Sep 3, 2025
03:46 AM EDT, 09/03/2025 (MT Newswires) -- Ronald N Tutor, 10% Owner, Director, Executive Chairman, on August 28, 2025, sold 80,660 shares in Tutor Perini ( TPC ) for $4,835,567. Following the Form 4 filing with the SEC, Tutor has control over a total of 6,620,029 common shares of the company, with 6,620,029 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/77543/000007754325000220/xslF345X05/wk-form4_1756858051.xml ...
Biogen, Eisai Begin FDA Rolling Submission for Early Alzheimer's Disease Drug
Biogen, Eisai Begin FDA Rolling Submission for Early Alzheimer's Disease Drug
Sep 3, 2025
04:23 AM EDT, 09/03/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said late Tuesday that Eisai has started the rolling submission of a supplemental biologics license application to the US Food and Drug Administration for subcutaneous lecanemab-irmb, intended to treat early Alzheimer's disease. The companies said the application is based on data from sub-studies within a phase 3 trial evaluating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved